Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06215287
Status:
COMPLETED
Last Update Posted:
2024-05-17
First Post:
2024-01-10
Brief Title:
Survey to Assess Physicians Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Study Overview
Official Title:
Survey to Assess Physicians Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this survey is to assess the knowledge of HCPs in relation to the recommended posology and biological monitoring for Exjade based on the current locally valid Exjade educational materials including the physicians reference checklist
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EUPAS104950 | OTHER | EU PAS registry | None |